Effect of Respiratory Training Protocols on GH Secretion in Obesity (ALRESPGHOB)
NCT ID: NCT05759598
Last Updated: 2023-03-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
3 participants
INTERVENTIONAL
2021-10-14
2022-06-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Project objectives are:
* assessment of GH-IGF-I responses (baseline), during the first training session of the respiratory muscles conducted in the first days of hospitalization of the patients in the clinic
* assessment of GH-IGF-I responses (post), during the last training session of the respiratory muscles conducted at the end of the three weeks of each training session
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mechanism of Growth Hormone Effects on Adipose Tissue
NCT00453557
Growth Hormone Treatment on Phosphocreatine Recovery in Obesity
NCT01421589
The Effects of Growth Hormone (GH) on Lipid Depots
NCT00491582
Effects of Growth Hormone and IGF-1 on Anabolic Signals and Stem Cell Recruitment in Human Skeletal Muscle
NCT03878992
Low Dose Growth Hormone Treatment in Subjects With Metabolic Syndrome.
NCT00720616
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Subjects The study provides for the recruitment of 20 obese boys/young adults aged between 14 and 30 years old hospitalized at the Division of Auxology and the Division of Metabolic Diseases, Istituto Auxologico Italiano, S. Giuseppe Hospital, Piancavallo (VB).
Criteria for inclusion in the study group are:
1. BMI standard deviation score (SDS)\>2 for patients \< 18 years and BMI\>35 for patients aged\>18 years;
2. absence of structured physical activity programs (regular activity for more than 120 minutes/week) during the 6 months preceding the study;
3. absence of signs/symptoms referable to cardiovascular, respiratory, gastrointestinal, or musculoskeletal pathologies contraindicated for carrying out the tests.
Materials and methods:
During the first respiratory training session (basal) and at the end of the three weeks of hospitalization (post) for an integrated metabolic rehabilitation program at the Division of Auxology (patients aged \< 18 years) and Division and Metabolic Diseases (adults) a blood sample is taken from each subject to determine the circulating levels of GH (total and isoforms 20 kDa and 22kDa) and cortisol in pre-training conditions and at times 0 ' (immediately at the end), +15', +30' and +60' (IGF-I levels are determined only in pre-workout conditions and immediately at the end). Blood samples taken after training are carried out by needle cannula during a saline infusion, to reduce the number of venipunctures. Lactate levels are determined by earlobe puncture in basal conditions, immediately at the end of the training session, and repeated every 2 minutes, until the peak value is reached.
In baseline conditions and at the end of the 3 weeks of respiratory training, body composition is evaluated (by impedance analysis), the maximum force developed during voluntary isometric contraction of the extensor and flexor muscles of the lower limb (by dynamometer), and spirometry is performed for the assessment of maximal lung capacity.
Respiratory muscle training protocol:
The recruited subjects are randomly divided into two homogeneous groups in terms of the number and basic characteristics of the subjects. A control group (CTRL) carries out the standard integrated metabolic rehabilitation protocol with the addition of guided spontaneous breathing exercises lasting about 20 minutes per session for 12 sessions.
An experimental group (RMT) carries out, in addition to the standard integrated metabolic rehabilitation protocol, a specific respiratory muscle training program according to the protocol recently proposed by Spengler et al. (Wuthrich et al., 2015; Schaer et al., 2018), adapted according to the baseline characteristics of the respiratory function of the subjects. The protocol includes 12 interval breathing training sessions, divided into 3 weeks (4 sessions/week) each lasting a total of about 12 minutes. Each respiratory training session includes 6 1-minute "sprint" breathing intervals followed by 1 minute of recovery. During the sprint intervals, the subjects breathe through a dedicated SpiroTiger instrument (Idiag AG, Fehraltorf, Switzerland) with the addition of a resistance (Schaer et al., 2018) which allows normocapnic hyperpnea against resistance. Subjects are asked to breathe at a respiratory rate of 25-30 breaths/minute with a constant tidal volume corresponding to approximately 60% of forced vital capacity. The target frequency is adjusted on an individual basis and is defined during the initial familiarization trials.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group (CTRL)
Rehabilitation protocol + guided spontaneous breathing exercises
Standard integrated metabolic rehabilitation protocol + guided spontaneous breathing exercises
Experimental group (RMT)
Rehabilitation protocol + specific respiratory muscle training program
Standard integrated metabolic rehabilitation protocol + specific respiratory muscle training program according to the protocol recently proposed by Spengler et al. (Wuthrich et al., 2015; Schaer et al., 2018), adapted according to the baseline characteristics of the respiratory function of the subjects
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Rehabilitation protocol + guided spontaneous breathing exercises
Standard integrated metabolic rehabilitation protocol + guided spontaneous breathing exercises
Rehabilitation protocol + specific respiratory muscle training program
Standard integrated metabolic rehabilitation protocol + specific respiratory muscle training program according to the protocol recently proposed by Spengler et al. (Wuthrich et al., 2015; Schaer et al., 2018), adapted according to the baseline characteristics of the respiratory function of the subjects
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* absence of structured physical activity programs (regular activity for more than 120 minutes/week) during the 6 months preceding the study;
* absence of signs/symptoms referable to cardiovascular, respiratory, gastrointestinal, or musculoskeletal pathologies contraindicated for carrying out the tests.
Exclusion Criteria
* presence of structured physical activity programs (regular activity for more than 120 minutes/week) during the 6 months preceding the study;
* presence of signs/symptoms referable to cardiovascular, respiratory, gastrointestinal, or musculoskeletal pathologies contraindicated for carrying out the tests.
14 Years
30 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istituto Auxologico Italiano
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istituto Auxologico Italiano, Site Piancavallo
Oggebbio, Verbania, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
01C020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.